慢性炎症性皮肤疾病中的炎症驱动分子衰老:生物疗法是否有作用?
Klara Andrzejczak1,2, Agata Sternak1,2, Wiktor Witkowski1,2
1Faculty of Medicine, Wroclaw Medical University, Wybrzeze L. Pasteura 1, 50-367 Wroclaw, Poland.
Cells
|September 26, 2025
概括
慢性炎症性皮肤疾病与全身衰老有关,由免疫激活和IL-17等细胞因子驱动. 针对这些途径的疗法可以减少由炎症驱动的衰老,皮肤疾病作为模型.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 老年学是一门学科.
背景情况:
- 慢性炎症性皮肤疾病 (例如,亚托皮炎,牛皮) 涉及到持续的免疫激活.
- 这些情况越来越多地与分子和血管衰老过程有关.
- 关键因素包括氧化应激,内皮功能障碍和长寿蛋白的改变表达 (Klotho, SIRT1).
研究的目的:
- 审查Th17和Th2炎症对全身炎症的贡献.
- 检查特定细胞因子 (IL-17,IL-23,IL-4,IL-13,IL-31) 在促进衰老特征中的作用.
- 探索生物疗法在缓解炎症驱动的衰老中的潜力.
主要方法:
- 现有文献的叙述性审查.
- 分析关键细胞因子在内皮损伤,氧化应激和代谢功能障碍中的作用.
- 鉴定血管生物标志物和免疫细胞衰老作为衰老指标.
主要成果:
- 通过特定的细胞因子介导的Th17和Th2炎症驱动系统性炎症.
- 细胞因子促进内皮损伤,氧化应激和代谢功能障碍.
- 血管生物标志物 (VCAM-1,ICAM-1,ST2,P-selectin) 和免疫细胞衰老都表明我们正在衰老.
结论:
- 慢性皮肤疾病可以作为研究系统性炎症的模型.
- 用生物药物向炎症驱动的衰老途径可能是有益的.
- 对皮肤疾病的早期干预可能会影响全身衰老过程.
更多相关视频
相关概念视频
Inflammatory Response
16.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.0K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
492
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
492
Inflammatory Bowel Disease IV: Pharmacological Management
521
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
521
Inflammation
61.7K
Overview
61.7K
The Effect of Aging on Tissues
3.4K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.4K
The JAK-STAT Signaling Pathway
12.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.1K


